DoubleLine ETF Adviser’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,749
Closed -$681K 183
2025
Q4
$681K Buy
6,749
+309
+5% +$33.5K 0.2% 112
2025
Q3
$794K Buy
+6,440
New +$799K 0.24% 105
2025
Q2
Sell
-5,780
Closed -$851K 162
2025
Q1
$851K Sell
5,780
-1,324
-19% -$202K 0.28% 92
2024
Q4
$1.15M Buy
7,104
+175
+3% +$28.6K 0.31% 89
2024
Q3
$1.13M Buy
6,929
+1,780
+35% +$264K 0.28% 97
2024
Q2
$703K Sell
5,149
-181
-3% -$25.1K 0.19% 108
2024
Q1
$816K Buy
+5,330
New +$796K 0.21% 109
2023
Q4
Sell
-4,259
Closed -$558K 209
2023
Q3
$558K Buy
+4,259
New +$647K 0.2% 95

Other funds holding CLX

DoubleLine ETF Adviser's CLX Position: Q1 2026 in Review

DoubleLine ETF Adviser sold out of Clorox (CLX) in Q1 2026, closing a stake of 6,749 shares — an estimated $681K sold.

DoubleLine ETF Adviser first reported a position in CLX in Q3 2023 and held it in 8 quarters. The position peaked at $1.15M in Q4 2024. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • DoubleLine ETF Adviser reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • DoubleLine ETF Adviser sold 6,749 Clorox shares in Q1 2026, an estimated $681K.
  • DoubleLine ETF Adviser first reported a position in Clorox in Q3 2023 and held it in 8 quarters.
  • DoubleLine ETF Adviser's Clorox position peaked at $1.15M in Q4 2024.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q1 2026, filed 15 May 2026.